Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Precision BioSciences Inc...

    NASDAQ: DTIL · Real-Time Price · USD
    5.31
    -0.18 (-3.28%)
    At close: Jun 09, 2025, 2:32 PM

    Precision BioSciences Statistics

    Share Statistics

    Precision BioSciences has 11.09M shares outstanding. The number of shares has increased by 51.35% in one year.

    Shares Outstanding

    n/a
    		 11.09M

    Shares Change (YoY)

    n/a
    		 51.35%

    Shares Change (QoQ)

    n/a
    		 36.64%

    Owned by Institutions (%)

    n/a
    		 56.45%

    Shares Floating

    n/a
    		 8.11M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,402

    FTD / Avg. Volume

    n/a
    		 3.94%

    Short Selling Information

    The latest short interest is 646.36K, so 5.83% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 646.36K

    Short % of Shares Out

    n/a
    		 5.83%

    Short % of Float

    n/a
    		 6.02%

    Short Ratio (days to cover)

    n/a
    		 6.92

    Valuation Ratios

    The PE ratio is 3.63 and the forward PE ratio is -1.1. Precision BioSciences's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 3.63

    Forward PE

    n/a
    		 -1.1

    PS Ratio

    n/a
    		 0.38

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 0.46

    P/FCF Ratio

    n/a
    		 -0.44

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    Precision BioSciences has an Enterprise Value (EV) of -29.82M.

    EV / Sales

    n/a
    		 -0.43

    EV / EBITDA

    n/a
    		 -2.2

    EV / EBIT

    n/a
    		 0.51

    EV / FCF

    n/a
    		 0.51

    Financial Position

    The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.53.

    Current Ratio

    n/a
    		 6.34

    Quick Ratio

    n/a
    		 6.34

    Debt / Equity

    n/a
    		 0.53

    Debt / EBITDA

    n/a
    		 2.22

    Debt / FCF

    n/a
    		 -0.51

    Interest Coverage

    n/a
    		 -14.68

    Financial Efficiency

    Return on Equity is 12.71% and Return on Invested Capital is -21.09%.

    Return on Equity

    n/a
    		 12.71%

    Return on Assets

    n/a
    		 5.25%

    Return on Invested Capital

    n/a
    		 -21.09%

    Revenue Per Employee

    n/a
    		 $636,074.07

    Profits Per Employee

    n/a
    		 $66,361.11

    Employee Count

    n/a
    		 108

    Asset Turnover

    n/a
    		 0.5

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -55.9% in the last 52 weeks. The beta is 1.47, so Precision BioSciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.47

    52-Week Price Change

    n/a
    		 -55.9%

    50-Day Moving Average

    n/a
    		 4.98

    200-Day Moving Average

    n/a
    		 6.46

    Relative Strength Index (RSI)

    n/a
    		 61.65

    Average Volume (20 Days)

    n/a
    		 136,957

    Income Statement

    In the last 12 months, Precision BioSciences had revenue of 68.7M and earned 7.17M in profits. Earnings per share was 1.05.

    Revenue

    n/a
    		 68.7M

    Gross Profit

    n/a
    		 68.7M

    Operating Income

    n/a
    		 -26.16M

    Net Income

    n/a
    		 7.17M

    EBITDA

    n/a
    		 13.53M

    EBIT

    n/a
    		 8.95M

    Earnings Per Share (EPS)

    n/a
    		 1.05
    Full Income Statement

    Balance Sheet

    The company has 85.9M in cash and 30.05M in debt, giving a net cash position of 55.85M.

    Cash & Cash Equivalents

    n/a
    		 85.9M

    Total Debt

    n/a
    		 30.05M

    Net Cash

    n/a
    		 55.85M

    Retained Earnings

    n/a
    		 -482.46M

    Total Assets

    n/a
    		 124.41M

    Working Capital

    n/a
    		 69.71M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -58.45M and capital expenditures -250K, giving a free cash flow of -58.7M.

    Operating Cash Flow

    n/a
    		 -58.45M

    Capital Expenditures

    n/a
    		 -250K

    Free Cash Flow

    n/a
    		 -58.7M

    FCF Per Share

    n/a
    		 -8.59
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -38.08% and 10.43%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -38.08%

    Pretax Margin

    n/a
    		 10.43%

    Profit Margin

    n/a
    		 10.43%

    EBITDA Margin

    n/a
    		 19.69%

    EBIT Margin

    n/a
    		 -38.08%

    FCF Margin

    n/a
    		 -85.44%

    Dividends & Yields

    DTIL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 27.53%

    FCF Yield

    n/a
    		 -225.46%
    Dividend Details

    Analyst Forecast

    The average price target for DTIL is $47, which is 773.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $47

    Price Target Difference

    n/a
    		 773.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 13.96

    Graham Upside

    n/a
    		 159.48%

    Stock Splits

    The last stock split was on Feb 14, 2024. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Feb 14, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -4.69

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist